| Primary |
| Depression |
58.6% |
| Major Depression |
7.9% |
| Anxiety |
5.2% |
| Insomnia |
4.8% |
| Bipolar Disorder |
3.9% |
| Blood Pressure Increased |
3.0% |
| Prophylaxis |
2.8% |
| Pain |
2.1% |
| Antioxidant Therapy |
1.5% |
| Blood Pressure |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypothyroidism |
1.1% |
| Asthma |
1.0% |
| Bipolar I Disorder |
1.0% |
| Panic Attack |
1.0% |
| Arthritis |
0.9% |
| Blood Cholesterol Increased |
0.9% |
| Thyroid Disorder |
0.9% |
| Arteriosclerosis |
0.7% |
| Autoimmune Thyroiditis |
0.6% |
|
| Application Site Reaction |
11.8% |
| Application Site Rash |
11.5% |
| Application Site Erythema |
8.3% |
| Drug Ineffective |
8.3% |
| Insomnia |
7.5% |
| Suicidal Ideation |
6.4% |
| Rash |
5.9% |
| Depression |
4.3% |
| Nausea |
4.3% |
| Application Site Irritation |
3.8% |
| Weight Increased |
3.5% |
| Application Site Pruritus |
2.9% |
| Application Site Urticaria |
2.9% |
| Palpitations |
2.9% |
| Weight Decreased |
2.9% |
| Dizziness |
2.7% |
| Headache |
2.7% |
| Blood Pressure Increased |
2.4% |
| Drug Effect Decreased |
2.4% |
| Fatigue |
2.4% |
|
| Secondary |
| Depression |
39.1% |
| Anxiety |
12.4% |
| Bipolar Disorder |
8.7% |
| Major Depression |
4.3% |
| Prophylaxis |
4.3% |
| Insomnia |
4.1% |
| Blood Pressure Increased |
3.4% |
| Antioxidant Therapy |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Suicidal Ideation |
2.4% |
| Autoimmune Thyroiditis |
2.2% |
| Pain |
2.2% |
| Hypothyroidism |
2.0% |
| Bipolar I Disorder |
1.8% |
| Panic Attack |
1.8% |
| Asthma |
1.4% |
| Blood Pressure |
1.4% |
| Delusion |
1.4% |
| Hepatic Steatosis |
1.4% |
| Arteriosclerosis |
1.2% |
|
| Blood Pressure Increased |
9.9% |
| Weight Increased |
9.0% |
| Dizziness |
7.2% |
| Suicidal Ideation |
7.2% |
| Wrong Technique In Drug Usage Process |
6.3% |
| Application Site Rash |
5.4% |
| Drug Ineffective |
5.4% |
| Application Site Reaction |
4.5% |
| Delusion |
4.5% |
| Emotional Poverty |
4.5% |
| Headache |
4.5% |
| Hyperhidrosis |
4.5% |
| Hypertensive Crisis |
4.5% |
| Insomnia |
4.5% |
| Application Site Erythema |
3.6% |
| Tremor |
3.6% |
| Abdominal Discomfort |
2.7% |
| Agitation |
2.7% |
| Fear |
2.7% |
| Hypotension |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.0% |
| Depression |
10.3% |
| Muscle Spasms |
5.0% |
| Anxiety |
4.5% |
| Back Pain |
4.5% |
| Crohn's Disease |
4.1% |
| Nausea |
4.1% |
| Insomnia |
3.7% |
| Pain |
3.7% |
| Bipolar Disorder |
3.3% |
| Parkinson's Disease |
2.9% |
| Abdominal Pain |
2.1% |
| Anaemia |
2.1% |
| Contraception |
2.1% |
| Gastritis |
2.1% |
| Osteoporosis |
2.1% |
| Premenstrual Syndrome |
1.7% |
| Vitamin D Decreased |
1.7% |
| Benign Prostatic Hyperplasia |
1.2% |
| Decreased Appetite |
0.8% |
|
| Hypomania |
9.7% |
| Therapeutic Response Unexpected |
9.7% |
| Vomiting |
9.7% |
| Burning Sensation |
6.5% |
| Gait Disturbance |
6.5% |
| Renal Failure Acute |
6.5% |
| Therapeutic Agent Toxicity |
6.5% |
| Weight Increased |
6.5% |
| Alopecia |
3.2% |
| Basal Cell Carcinoma |
3.2% |
| Crying |
3.2% |
| Emotional Distress |
3.2% |
| Fall |
3.2% |
| Generalised Oedema |
3.2% |
| Inappropriate Schedule Of Drug Administration |
3.2% |
| Injection Site Swelling |
3.2% |
| Memory Impairment |
3.2% |
| Nausea |
3.2% |
| Night Sweats |
3.2% |
| Oedema Peripheral |
3.2% |
|
| Interacting |
| Depression |
26.1% |
| Anxiety |
21.7% |
| Gastrooesophageal Reflux Disease |
8.7% |
| Product Used For Unknown Indication |
8.7% |
| Application Site Pruritus |
4.3% |
| Asthma |
4.3% |
| Bipolar Disorder |
4.3% |
| Blood Pressure Increased |
4.3% |
| Dyspepsia |
4.3% |
| Hypothyroidism |
4.3% |
| Thrombosis Prophylaxis |
4.3% |
| Wheezing |
4.3% |
|
| Drug Interaction |
33.3% |
| Coordination Abnormal |
11.1% |
| Depression |
11.1% |
| International Normalised Ratio Increased |
11.1% |
| Serotonin Syndrome |
11.1% |
| Visual Disturbance |
11.1% |
| Withdrawal Syndrome |
11.1% |
|
